Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma

Lymphoma-specific biomarkers contribute to therapeutic strategies and the study of tumorigenesis. Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. However, only 50% of patients experience long-term survival after current treatment; therefore, developing novel ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kung-Chao, Chang, Wei-Chao, Chang, Yao, Hung, Liang-Yi, Lai, Chien-Hsien, Yeh, Yu-Min, Chou, Yu-Wei, Chen, Chung-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819250/
https://www.ncbi.nlm.nih.gov/pubmed/24223200
http://dx.doi.org/10.1371/journal.pone.0079863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819250/
https://www.ncbi.nlm.nih.gov/pubmed/24223200
http://dx.doi.org/10.1371/journal.pone.0079863

Ejemplares similares